OrbusNeich Medical Group Holdings Limited

SHSC:6929 Stock Report

Market Cap: HK$3.2b

OrbusNeich Medical Group Holdings Future Growth

Future criteria checks 2/6

OrbusNeich Medical Group Holdings is forecast to grow earnings and revenue by 7.6% and 12.7% per annum respectively. EPS is expected to grow by 2.6% per annum. Return on equity is forecast to be 10.6% in 3 years.

Key information

7.6%

Earnings growth rate

2.6%

EPS growth rate

Medical Equipment earnings growth40.3%
Revenue growth rate12.7%
Future return on equity10.6%
Analyst coverage

Low

Last updated16 Feb 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SHSC:6929 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202623444N/AN/A1
12/31/20252045148543
12/31/20241764441483
12/31/20231524130333
6/30/2023149361822N/A
3/31/2023143271923N/A
12/31/2022137182023N/A
9/30/202213291922N/A
6/30/202212801820N/A
3/31/2022122-21820N/A
12/31/2021116-41820N/A
12/31/2020887913N/A
12/31/2019967-12N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6929's forecast earnings growth (7.6% per year) is above the savings rate (2%).

Earnings vs Market: 6929's earnings (7.6% per year) are forecast to grow slower than the Hong Kong market (12.4% per year).

High Growth Earnings: 6929's earnings are forecast to grow, but not significantly.

Revenue vs Market: 6929's revenue (12.7% per year) is forecast to grow faster than the Hong Kong market (8.1% per year).

High Growth Revenue: 6929's revenue (12.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 6929's Return on Equity is forecast to be low in 3 years time (10.6%).


Discover growth companies